Cargando…

When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression

Late-life depression (LLD) and Alzheimer's Disease (AD) are the two most frequent neuropsychiatric disorders affecting elderly. LLD and AD may clinically present with depressive and cognitive symptoms. Therefore, when cognitive decline is coupled with depression in the elderly, the differential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liguori, Claudio, Pierantozzi, Mariangela, Chiaravalloti, Agostino, Sancesario, Giulia M., Mercuri, Nicola B., Franchini, Flaminia, Schillaci, Orazio, Sancesario, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829060/ https://www.ncbi.nlm.nih.gov/pubmed/29527163 http://dx.doi.org/10.3389/fnagi.2018.00038

Ejemplares similares

Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and (18)F-FDG PET Study
por: Chiaravalloti, Agostino, et al.
Publicado: (2016)

Sleep Dysregulation Is Associated with (18)F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
por: Fernandes, Mariana, et al.
Publicado: (2023)

Functional Correlates of Microglial and Astrocytic Activity in Symptomatic Sporadic Alzheimer’s Disease: A CSF/(18)F-FDG-PET Study
por: Bonomi, Chiara Giuseppina, et al.
Publicado: (2023)

Association between hearing sensitivity and dopamine transporter availability in Parkinson’s disease
por: Garasto, Elena, et al.
Publicado: (2023)

(18)F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment
por: Fernandes, Mariana, et al.
Publicado: (2022)

Tau and Amyloid-β Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters
por: Schirinzi, Tommaso, et al.
Publicado: (2022)

Serotonin Impairment in CSF of PD Patients, without an Apparent Clinical Counterpart
por: Olivola, Enrica, et al.
Publicado: (2014)

Artificial Intelligence for Alzheimer’s Disease: Promise or Challenge?
por: Fabrizio, Carlo, et al.
Publicado: (2021)

Blood–Brain Barrier Dysfunction and Aβ42/40 Ratio Dose-Dependent Modulation with the ApoE Genotype within the ATN Framework
por: Toniolo, Sofia, et al.
Publicado: (2023)

How Comorbidity Reflects on Cerebrospinal Fluid Biomarkers of Neurodegeneration in Aging
por: Zenuni, Henri, et al.
Publicado: (2021)

Subependymal Spread of Glioblastoma Multiforme in Positron Emission Tomography/Computed Tomography
por: Chiaravalloti, Agostino, et al.
Publicado: (2017)

Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?
por: Chiurchiù, Valerio, et al.
Publicado: (2022)

In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases
por: Sala, Arianna, et al.
Publicado: (2021)

Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson’s Disease
por: Liguori, Claudio, et al.
Publicado: (2015)

Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology
por: Lattanzi, Roberta, et al.
Publicado: (2019)

The Brain Metabolic Correlates of the Main Indices of Neuropsychological Assessment in Alzheimer’s Disease †
por: Chiaravalloti, Agostino, et al.
Publicado: (2020)

Depressive and anxiety symptoms in patients with SARS-CoV2 infection
por: Liguori, Claudio, et al.
Publicado: (2021)

Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay
por: Cariulo, Cristina, et al.
Publicado: (2019)

Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
por: Cimini, Andrea, et al.
Publicado: (2020)

Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia
por: Ricci, Maria, et al.
Publicado: (2020)

Molecular Imaging in Pediatric Brain Tumors
por: Chiaravalloti, Agostino, et al.
Publicado: (2019)

Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective
por: Ricci, Maria, et al.
Publicado: (2021)

Aggregation States of Aβ(1–40), Aβ(1–42) and Aβp(3–42) Amyloid Beta Peptides: A SANS Study
por: Festa, Giulia, et al.
Publicado: (2019)

Transient global amnesia: Linked to a systemic disorder of amino acid catabolism?
por: Sancesario, Giuseppe, et al.
Publicado: (2013)

Effects of head trauma and sport participation in young-onset Parkinson’s disease
por: Schirinzi, Tommaso, et al.
Publicado: (2021)

Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence
por: Liguori, Claudio, et al.
Publicado: (2022)

Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: a F-18 FDG PET/CT study
por: Chiaravalloti, Agostino, et al.
Publicado: (2017)

A Rare Case of Primary Uterine Non-Hodgkins's Lymphoma with Involvement of Right Ovary: Staging with 18F FDG PET/CT and Iodinated Contrast CT
por: Lamacchia, Feliciana, et al.
Publicado: (2019)

A Patient with a Benign and a Malignant Primary Pulmonary Meningioma: An Evaluation with 18F Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Computed Tomography with Iodinated Contrast
por: Cimini, Andrea, et al.
Publicado: (2019)

MGMT Promoter Methylation and IDH1 Mutations Do Not Affect [(18)F]FDOPA Uptake in Primary Brain Tumors
por: Cimini, Andrea, et al.
Publicado: (2020)

A Rare Case of Pulmonary Schistosomiasis: (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Findings
por: Cimini, Andrea, et al.
Publicado: (2020)

Secondary neurodegeneration following Stroke: what can blood biomarkers tell us?
por: Brunelli, Stefano, et al.
Publicado: (2023)

Neuropathology of the Basal Ganglia in SNCA Transgenic Rat Model of Parkinson’s Disease: Involvement of Parvalbuminergic Interneurons and Glial-Derived Neurotropic Factor
por: Paldino, Emanuela, et al.
Publicado: (2022)

Prognostic Value of (18)F-Choline PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223
por: Filippi, Luca, et al.
Publicado: (2020)

Dyspnea perception and neurological symptoms in non-severe COVID-19 patients
por: Ora, Josuel, et al.
Publicado: (2020)

Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

18F-FDOPA PET/CT SUV-Derived Indices and Volumetric Parameters Correlation in Patients with Primary Brain Tumors
por: Chiaravalloti, Agostino, et al.
Publicado: (2021)

Restless Legs Syndrome and Poliomyelitis: New Evidences of an Old Observation?
por: Romigi, Andrea, et al.
Publicado: (2015)

Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations
por: Fernandes, Mariana, et al.
Publicado: (2021)

Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s4m0t199t57q7c4g8tagrvp60u